May 25, 2020
Medical Scientist Dr. Gagandeep Kang talks to host Pavan Srinath about ongoing drug development efforts against COVID-19. She discusses the challenges of developing antiviral medicines and lays out the unprecedented efforts taking place to test drugs old and new, against the novel Coronavirus.
In case you missed it, Dr. Kang was previously on Episode 8 of BIC Talks, ‘A Quest for Immunity’, to talk about vaccine development against COVID-19.
Dr. Gagandeep Kang is a 2016 Infosys Prize laureate, and is currently the Executive Director of the Translational Health Science and Technology Institute. Dr Kang is a key contributor to the understanding of diarrhoeal diseases, rotavirus epidemiology and vaccinology in India, with a stellar career at Christian Medical College Vellore. She is also the Chair of the National Technical Advisory Group for Immunisation and the Vice Chair for the Coalition of Epidemic Preparedness and Innovations.
BIC Talks is brought to you by the Bangalore International Centre. Visit the BIC website for show notes, links and more information about the guest.